🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 04/09/1996 | 0,1908 USD |
| 06/06/1996 | 0,1622 USD |
| 06/03/1996 | 0,1622 USD |
| 06/12/1995 | 0,1622 USD |
| 05/09/1995 | 0,1622 USD |
| 02/06/1995 | 0,1431 USD |
| 03/03/1995 | 0,1431 USD |
| 02/12/1994 | 0,1431 USD |
| 02/09/1994 | 0,1431 USD |
| 02/06/1994 | 0,1336 USD |
| 02/03/1994 | 0,1336 USD |
| 02/12/1993 | 0,1336 USD |
| 02/09/1993 | 0,1336 USD |
| 02/06/1993 | 0,1193 USD |
| 02/03/1993 | 0,1193 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 12/09/1990 | 12,96 | 12,98 | 12,78 | 12,90 | -0,31% | 1,53% | 2.933.981 |
| 11/09/1990 | 12,86 | 12,96 | 12,76 | 12,94 | +0,46% | 1,55% | 3.181.099 |
| 10/09/1990 | 13,16 | 13,16 | 12,82 | 12,88 | -0,15% | 2,57% | 3.553.978 |
| 07/09/1990 | 12,64 | 12,94 | 12,64 | 12,90 | +1,57% | 2,36% | 3.067.915 |
| 06/09/1990 | 12,84 | 12,86 | 12,62 | 12,70 | -1,69% | 1,86% | 3.098.098 |
| 05/09/1990 | 12,94 | 13,00 | 12,76 | 12,92 | -0,31% | 1,84% | 3.188.645 |
| 04/09/1990 | 12,84 | 12,96 | 12,68 | 12,96 | -0,15% | 2,17% | 3.467.832 |
| 31/08/1990 | 12,76 | 12,98 | 12,62 | 12,98 | +2,03% | 2,80% | 2.702.582 |
| 30/08/1990 | 13,04 | 13,08 | 12,64 | 12,72 | -2,44% | 3,35% | 3.665.275 |
| 29/08/1990 | 12,80 | 13,12 | 12,80 | 13,04 | +1,39% | 2,48% | 4.765.675 |
| 28/08/1990 | 12,76 | 12,98 | 12,74 | 12,86 | -0,15% | 1,87% | 4.071.480 |
| 27/08/1990 | 12,86 | 13,04 | 12,80 | 12,88 | +4,35% | 1,85% | 7.433.674 |
| 24/08/1990 | 12,36 | 12,44 | 12,01 | 12,34 | +1,47% | 3,54% | 7.837.363 |
| 23/08/1990 | 12,13 | 12,38 | 12,01 | 12,17 | -2,55% | 3,11% | 8.854.762 |
| 22/08/1990 | 12,92 | 12,98 | 12,48 | 12,48 | -3,38% | 3,85% | 5.612.040 |
| 21/08/1990 | 12,84 | 13,10 | 12,64 | 12,92 | -1,37% | 3,56% | 9.101.251 |
| 20/08/1990 | 13,06 | 13,12 | 12,90 | 13,10 | +0,30% | 1,67% | 3.810.528 |
| 17/08/1990 | 13,20 | 13,28 | 12,88 | 13,06 | -1,94% | 3,01% | 12.922.469 |
| 16/08/1990 | 13,80 | 13,88 | 13,28 | 13,32 | -4,69% | 4,32% | 4.463.222 |
| 15/08/1990 | 13,88 | 14,03 | 13,86 | 13,98 | +1,01% | 1,29% | 2.984.285 |
| 14/08/1990 | 13,78 | 13,94 | 13,70 | 13,84 | +0,14% | 1,73% | 4.487.117 |
| 13/08/1990 | 13,36 | 13,82 | 13,24 | 13,82 | +2,51% | 4,32% | 4.639.915 |
| 10/08/1990 | 13,60 | 13,60 | 13,30 | 13,48 | -1,45% | 2,19% | 3.489.840 |
| 09/08/1990 | 13,52 | 13,68 | 13,50 | 13,68 | +1,03% | 1,32% | 3.612.456 |
| 08/08/1990 | 13,30 | 13,66 | 13,26 | 13,54 | +2,56% | 2,99% | 6.719.986 |
| 07/08/1990 | 13,36 | 13,42 | 13,18 | 13,20 | +0,61% | 1,79% | 8.598.211 |
| 06/08/1990 | 13,00 | 13,32 | 12,92 | 13,12 | -3,51% | 3,06% | 8.093.285 |
| 03/08/1990 | 13,56 | 13,64 | 13,08 | 13,60 | -2,01% | 4,11% | 11.307.082 |
| 02/08/1990 | 14,03 | 14,13 | 13,84 | 13,88 | -2,92% | 2,12% | 6.099.989 |
| 01/08/1990 | 14,21 | 14,31 | 14,11 | 14,29 | +0,84% | 1,40% | 5.825.203 |